| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |